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Summary. Radioligand binding to A1 adenosine recep-
tors at brain membranes from seven species was investi-
gated. The antagonist 8-cyclopentyl-1 ,3-[3H]dipropyl-
xanthine ([3H]DPCPX) bound with affinities between 
0.17 nM in sheep brain and 2.1 nM in guinea pig brain. 
Competition of several antagonists for [3H]DPCPX bind-
ing showed that the most potent compounds were 
DPCPX with Ki values of 0.05 nM in bovine brain and 
1.1 nM in guinea pig brain and xanthine amine congener 
(XAC) with Ki values of 0.03 nM in bovine brain and 
5.5 nM in guinea pig brain. The differences in affinity of 
the agonist radio Iigand 2-chloro-}j6 -[3H]cyclopen tyl-
adenosine ([3H]CCP A) were less pronounced, rauging 
from a K0 value of 0.12 nM (hamster brain) to 0.42 nM 
(guinea pig brain). Agonist competition for [3H]DPCPX 
binding of photoaffinity labelling, however, exhibited 
marked species differences. N-Ethylcarboxamidoa-
denosine (NECA) and S-}j6-phenylisopropyladenosine 
(S-PIA) showed 20 to 25-fold different K0 values in differ-
ent species. NECA had a particularly high affinity in 
guinea pig brain and was only two-fold less potent than 
R-PIA. Thus, the difference from the "classical" A1 re-
ceptor profile (R-PIA > -NECA > S-PIA) is not sufficient 
to speculate that A 1 receptor subtypes may exist that are 
coupled to different effector systems. Our data show that 
these difference can easily be explained by species differ-
ences. 
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Introduction 
Adenosine receptors have been characterized in different 
tissues by both functional and binding studies (for review 
Send offprint requests to K.-N. Klotz at this address: Department 
of Chemistry, MontanaState University, 32 Gaines Hall, Bozeman, 
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see Lohse et al. (1988 a). On the basis of their coupling to 
adenylate cyclase, two subtypes have been distinguished 
(van Calker et al. 1978). The A1 subtype inhibits 
adenylate cyclase via the inhibitory guanine nucleotide-
binding protein Gj, while the A2 receptor stimulates 
cyclase via Gs. Several reports have recently shown that 
adenosine receptors are also coupled to other effector 
systems (Belardinelli and Isenberg 1983; Kurachi et al. 
1986; Kurtz 1987; Arend et al. 1988) and, therefore, it is 
also reasonable to distinguish receptor subtypes on the 
basis of the rank order of potency of agonists and antag-
onists (Londos et al. 1980). The "classical" agonistrank 
order of potency for an A1 receptor is R-PIA-
> NECA > S-PIA, with pronounced stereoselectivity for 
the PIA (N6 -phenylisopropyladenosine) diastereomers, 
while the A2 receptor is defined by NECA>R-PIA>S-
PIA and a low stereoselectivity for the PIA diastereomers. 
With these criteria, adenosine receptors of some tis-
sues - e. g. cardiac receptors - are not easily referred 
to the A 1 or A2 subtype. In several functional studies 
with guinea pig hearts NECA has been shown tobe as 
potent as R-PIA (Brückner et al. 198 5; Leung et al. 1986; 
von der Leyen et al. 1989). Similar results have also 
been obtained in binding experiments in guinea pig atria 
(Tawfik-Schlieper et al. 1989). The different pharmaco-
logical profile compared with the rat brain receptor and 
the different effector coupling led to the speculation that 
the cardiac adenosine receptor may represent an A1 re-
ceptor subtype. 
It has been shown in rat heart, on the other band, 
that R-PIA is about seven times morepotent than NECA 
in the depression of heart rate (Oei et al. 1988). Binding 
studies with rat ventricular myocytes (Martens et al. 1988) 
and membranes from rat ventricular myocytes (Martens 
et al. 1987) showed a pharrnacological profile which 
closely resembled the classical agonist profile. The notion, 
however, that cardiac A1 receptors may represent a sub-
dass is mainly based on the data from guinea pig hearts. 
It is important, therefore, to exclude the idea that the 
observed differences are only species differences. Binding 
Table 1. Binding parameters of brain membranes from different 
species for [3H]DPCPX binding 
Species Ko Bmax 
(nM) (frnolfrng) 
Sheep 0.17 (0.11-0.27) 2150 ± 165 
Bovine 0.22 (0.15 -0.31) 1350 ± 130 
Harnster 0.50 (0.39- 0.63) 4090 ± 720 
Rat 0.51 (0.35-0.77) 1090 ± 140 
Rahbit 0.72 (0.35 -1.45) 1970 ± 240 
Pig 0.76 (0.40-1.47) 590 ± 80 
Guinea pig 2.08 (1.08 -4.00) 1600 ± 300 
Data shown are means from 3 to 4 separate saturation experiments 
in each case. K0 values are shown with 95% confidence Iimits in 
brackets and Bmax values are given ±·SEM 
studies at A1 receptors in brain membranes showed that 
species differences exist (Bruns et al. 1980; Murphy and 
Snyder 1982; Ferkany et al. 1986), in particular for 8-
substituted xanthine derivatives (Hamilton et al. 1985; 
Schwabeet al. 1985; Jacobson et al. 1986). We now inves-
tigate whether different agonist profiles at A 1 receptors 
in several species may account for the different functional 
data reported by several groups compared with the classi-
cal A1 profile. We compared adenosine receptors from 
brain membranes as the typical source for A 1 receptors 
from seven species by means of radioligand binding. 
A 1 receptors were defined by labelling with the highly 
A 1 selective ligands [3H]DPCPX (antagonist) and 
[3 H]CCP A (agonist) and the consistently observed high 
· stereoselectivity for the PIA diastereomers. In addition, 
the A 1 receptors from different sources were compared 
by photoaffinity labelling with R-2-azido-N'-1251-p-
hydroxyphenylisopropyladenosine (1251-AHPIA, Klotz 
et al. 1985). Comparison ofthe pharmacological agonist 
profiles from brain membranes with binding and func-
tional data from other tissues in the respective species 
should facilitate in distinguishing new receptor subtypes 
and species differences. 
Materials and methods 
Materials. [3H]CCPA was purchased from Du Pont-New England 
Nuclear (Dreieich, FRG) and [3H]DPCPX from Amersham Buchler 
(Braunschweig, FRG). AHPIA was iodinated to give 1251-AHPIA 
with a specific radioactivity of about 74 TBqfmmol (Klotzet al. 
1985). DPCPX (8-cyclopentyl-1,3-dipropylxanthine) and CCPA 
were synthesized as previously described (Lohse et al. (1987, 1988 b, 
respectively). 8-Cyclopentyl-theophylline (CPT) was from RBI 
(Natick, Mass, USA). Xanthine amino congener (XAC) was a kind 
gift ofDr. Entzeroth (Thomae, Biberach, FRG). All other chemieals 
were of the highest purity available. 
Preparation of membranes. Brain membranes from all species were 
prepared as described earlier (Lohse et al. 1984) frorn whole brain, 
with the exception of bovine brain from wbich only the cortex was 
used (no difference has been observed for the K 0 values for the 
agonist PH]N6-cyclohexyladenosine ([3 H]CHA) in different calf-
brain areas; Murphy and Snyder 1982). 
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Table 2. Competition of antagonists for [3H]DPCPX binding (data 
from representative experiments) 
Species K1 (nM) 
DPCPX XAC CPT Theophylline 
Sheep 0.10 0.09 2.9 9050 
Bovine 0.05 0.03 1.4 6330 
Hamster 0.14 0.31 4.3 4550 
Rat 0.18 0.49 6.3 5600 
Rahbit 0.21 0.45 6.4 4710 
Pig 0.23 1.48 4.5 5980 
Guinea pig 1.06 5.49 26.1 7060 
CPT, cyclopentyl-theophylline; DPCPX, 8-cyclopentyl-1 ,3-diprop-
ylxanthine; XAC, xanthine amino congener 
Table 3. Binding parameters of brain membranes from different 
species for [3H]CCP A binding 
Species Ko Bmax 
(nM) (fmol/mg) 
Sheep 0.15 (0.12-0.18) 1920 ± 250 
Bovine 0.22 (0.16-0.29) 1100 ± 20 
Hamster 0.12 (0.11- 0.13) 1630 ± 60 
Rat 0.20 (0.17- 0.23) 880 ± 30 
Rabbit 0.24 (0.22- 0.26) 1440 ± 30 
Pig 0.31 (0.24-0.42) 500 ± 80 
Guinea pig 0.42 (0.31 ~0.58) 1190 ± 110 
Data shown are means from 3 to 4 separate saturation experiments. 
K0 -values are shown with 95% confidence Iimits in brackets and 
Bmax values are shown ± SEM 
Radioligand binding. Binding of f3H]DPCPX was perforrned accord-
ing to Lohse et al. (1987) and binding ofeH]CCPA was performed 
as described recently (Klotzet al. 1989). In competition experiments 
0.2-0.5 nM [3H]DPCPX with 30- 50 11g protein in a total volume 
of 250 J1l was used. Nonspecific binding of eHJDPCPX and 
[ 3H]CCPA was determined in the presence of 10 11M R-PIA and 
1 mM theophylline, respectively. Adenosine deaminase was present 
in all binding assays at a concentrations of 0.2 U/ml. Each value 
was determined in duplicate. Data were analysed by nonlinear curve-
fitting with the program SCTFIT as described by Lohse et al. (1987). 
Two affinity states were assumed in competition experiments when 
curve fitting according to a two-site model significantly improved 
the fit (p < 0.001). 
Photoaffinity labe/ling. Photoaffinity labeHing of A1 receptors in 
brain rnembranes was performed with 1251-AHPIA at a concen-
tration of about 200 pM as described elsewhere (Klotz et al. 1985; 
Klotz and Lohse 1986). In brief, rnembranes (approximately 250 j.Lg) 
were incubated for 2-3 h with 1251-AHPIA (500000 cpm) in a total 
volume of 750 111 in the dark in the presence and absence of 1 mM 
theophylline to define non-specific labelling. Then mernbranes were 
UV -irradiated and prepared for sodiurndodecyl sulfate- polyacryl-
arnide gel electrophoresis (SDS-PAGE) on 10% gels. The gels were 
stained with Coomassie Blue and then dried for autoradiography 
(Klotzet al. 1985). 
Results 
Saturationexperiments with brain membranes from dif-
ferent species showed that marked differences in affinity 
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Fig. l. Competition of agonists for 
· eH]DPCPX binding. Membranes 
from different brains were 
incubated with 0.2-0.5 nM 
[3H]DPCPX and inc~easing 
concentrations of agonists at 
25° C. Data are shown from 
representative experiments. K1 
values for agonists from multiple 
experiments are summarized in 
Table 4 for all species·. CCP A, 
2-chloro-JVf> -[3H]cyclopen tyl-
adenosine; NECA, N-ethylcarbox-
amidoadenosine; R-PIA, R-N6 -
phenylisopropyladenosine; S-P/A, 
S-.ff> -phenylisopropyiadenosine 
GONCENTRATION OF AGONIST (Ml 
Table 4. Competition of agonists for eH]DPCPX binding. Ki values (nM) are given for high and low affinity states (KH and KL, respectively) 
for each agonist. Bmax values are sums of high and low affinity states (fmol/mg protein) and % RH shows the percentage of receptors in the 
high affinity state 
Species CCPA R-PIA 
KH KL KH KL 
Sheep 0.98 39.3 0.36 6.9 
Bovine 0.15 7.7 0.03 1.6 
Hamster 0.39 23.2 0.94 35.9 
Rat 0.23 16.1 0.51 20.8 
Rahbit 0.20 8.5 0.31 13.5 
Pig 0.15 4.0 0.27 4.5 
Guineapig 0.59 39.7 0.89 66.6 
Data are mean values from 3 to 6 experiments 
and receptor density exist for the A1 receptor-selective 
antagonist [3H]DPCPX (Table 1 ). The affinity was the 
highest at sheep brain receptors with a K0 value of 
0.17 nM and the lowest with 2.1 nM at the guinea pig 
receptor. The Bm~x values ranged from about 600 fmol/ 
mg in pig brain mem branes up to 4000 fmol/mg protein in 
hamster brain membranes (Table 1). The marked species 
differences for 8-substituted xanthine derivatives was also 
documented by antagonist competition for [3H]DPCPX 
binding (Table 2). Theophylline had similar affinities in 
all species under investigation, while DPCPX, XAC and 
CPT exhibited 20- to 100-fold higher K0 values in guinea 
pig brain compared to bovine brain. 
The species difference was less pronounced for the 
affinity of the A1 receptor-selective agonist [3H]CCPA. 
A 1 receptors from hamster brain had a K0 value of 
0.12 nM, and at guinea pig brain receptors a K0 value of 
0.42 nM was measured (Table 3). The receptor densities 
determined with [3H]CCPA were lower than those values 
S-PIA NECA Bmax %Ru 
KH KL ·Ku KL 
8.3 366 32.9 2333 2030 51 
1.3 69 13.4 466 1700 52 
30.5 1763 4.2 277 2220 57 
29.1 1490 3.7 170 960 56 
10.3 534 5.3 85 1680 46 
16.8 386 5.3 161 630 40 
33.1 2985 1.8 129 1480 42 
obtained with [3H]DPCPX, because only high affinity 
binding was tested (Table 3). 
The pharmacological profile of agonists for the recep-
tors from different species was determined in competition 
experiments. Competition for binding of the antagonist 
[ 3H]DPCPX resulted in biphasic curves, which are 
characteristic for the presence of receptors in high- and 
Iow-affinity states for agonists. Figure 1 gives an example 
for the profiles of four different species. Strikingly, the 
differences between the three agonists CCPA, R-PIA and 
NECA are only very small at A1 receptors from guinea 
pig brain membranes compared to membranes from 
other species. The difference between R-PIA and NECA 
is less than two-fold in guinea pig brain, compared to 20-
fold in pig brain, for example. In sheep and bovine brain 
a different rank order of potency of agonists was found. 
In these species, R-PIA is morepotent than CCPA, and 
S-PIA is more potent than NECA. The sum of high and 
low affinity Bmax values calculated from the competition 
Fig. 2. Photoaffinity labeHing of A1 adenosine receptors in brain 
rnembranes from different species; autoradiograms from dried SOS-
PAGE gels. Nonspecific labeHing is defined in the presence of 1 mM 
theophylline (THEO). DFindicates the dye front. In bovine, sheep, 
pig, rat and hamster brain, a band with an apparent molecular 
weight of 35 000 is specifically labelled 
data compares readily with the Bmax values estimated in 
saturation experiments with [3H]-DPCPX (Table 1). The 
proportion of receptors in the high affinity state ranged 
from about 40% to 60%. Data for all species investigated 
in this paper are summarized in Table 4. 
To further show differences of A1 receptors from 
different species, photoaffinity labeHing experiments were 
done. A1 receptors can be labelled with 125I-AHPIA with 
high yield in rat brain membranes (Klotzet al. 1985) and 
similarly in hamster brain (Fig. 2). In bovine and sheep 
brain, labeHing was less effective, and only poor labelling 
occurred in pig brain. In rabbit and guinea pig brain 
membranes, no specific labeHing of an A1 receptor was 
observed. All labelled receptors from different sources 
bad the same apparent molecular weight of 35000. The 
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Table S. Specific binding of 1251-AHPIA to membranes from differ-
ent tissue. Shown is specific binding in the photoaffinity labeHing 
protocol after UV irradiation. Photoincorporation of the label is 
given relatively as very good labelling ( + + +) to no labelling (-) 
Tissue cpm LabeHing 
Sheep 205800 ++ 
Bovine 192500 ++ 
Hamster 46500 +++ 
Rat 32000 +++ 
Rahbit 23900 
Pig 20600 + 
Guinea pig 6100 
poor or missing incorporation yield of 125I-AHPIA was 
not caused by a Iack of binding to the respective A1 
receptors. 1251-AHPIA readily bound to all the different 
membranes, and the amount of bound 1251-AHPIA does 
not correlate to the photoincorporation of the Iabel 
(Table 5). 
Discussion 
Species differences for antagonist binding at A 1 
adenosine receptors are weil documented. In particular, 
several 8-substituted methyl xanthines have been shown 
to exhibit marked differences in affinity for A1 receptors 
from rat and bovine brain (Hamilton et al. 1985; Schwabe 
et al. 1985; Jacobson et al. 1986). The A 1 selective antag-
onist [3H] DPCPX has been shown to bind with sub-
nanomolar affinity to rat and bovine brain A1 receptors 
(Lohse et al. 1987), while a K0 value of 2.3 nM was 
reported for guinea pig brain receptors (Ströher et al. 
1989). Saturation experiments with [3H]DPCPX confirm 
these observations (Table 1). Similar differences for bo-
vine and guinea pig brain were also reported for [3H]XAC 
(Jacobson et al. 1986). 
Differences in agonist affinities at rat and bovine 
brain A 1 receptors seem tobe less pronounced (Murphy 
and Snyder 1982; Ferkany et al. 1986; Jacobson et al. 
1987). Consistently, [3H]CCPA exhibited K 0 values 
which varied by only a factor of 3- 4 in the seven species 
investigated in this paper (Table 3). The high- and low-
affinity agonist profiles clearly demonstrate an important 
difference between several species (Table 4). While the 
high-affinity K0 values for CCPA as well as for R-PIA 
(with the exception of bovine brain) differ by a factor of 
not more than 6, up to 25-fold differences were observed 
for NECA and S-PIA. In particular, the guinea pig brain 
exhibits an unusually high affinity for NECA, with a K0 
of 1.8 nM. Thus, only minor potency differences exist in 
guinea pig brain for CCPA, R-PIA and NECA. This is 
consistent with the binding and 86Rb + efflux data of the 
K + channel-coupled adenosine receptor from guinea pig 
atria (Tawfik-Schlieper et al. 1989). The striking feature 
of guinea pig cardiac tissue seems tobethat only a minor 
difference occurs in the potency of R-PIA and NECA 
(Brücknereta1.1985; Leungetal.1986; Tawfik-Schlieper 
et al. 1989). The binding data for guinea pig brain 
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(Table 4) and from guinea pig atria (Tawfik-Schlieper et 
al. 1989) suggest that the same adenosine receptors exist 
in both nervous and cardiac tissue. 
A recent report by Leid et al. ( 1989) also showed an 
atypical agonist profile of the solubilized porcine atrial 
A1 receptor. It is conspicuous that NECA and S-PIA are 
almost equipotent at this receptor. The same character-
istic profile was detected for the A 1 receptor in pig brain 
membranes (Table 4). 
In sheep and bovine brain not only were different 
potencies for particular agonists found, but even a differ-
ent rank order of agonist potency was observed. Strik-
ingly, R-PIA was found tobemorepotent than CCPA, 
and S-PIA was more potent than NECA. These resu1ts 
show that fundamental differences may exist foragonist 
profiles at A1 receptors from different species. 
Species variations can be visualized by photoaffinity 
labeHing with 1251-AHPIA. The dramatic differences in 
the photoincorporation yield, which are not related to 
receptor binding of the photoaffinity Iigand (Table 5), 
confirm the existence of species-dependent variations in 
the agonist-binding domain of A1-receptors. 
In the past, evidence accumulated that A1 receptors 
may be coupled not only with adenylate cyclase but also 
with other effector systems (Belardinelli and Isenberg 
1983; Kurachi et al. 1986; Kurtz 1987; Arend et al. 1988), 
probably via different guanine nucleotide binding pro-
teins. The copurification of At receptors with different 
G protein tX subunits from bovine brain (Munshi and 
Linden 1989) supports the idea that A1 receptors couple 
to different G proteins. This may possibly allow different 
potencies for one agonist in mediating different intra-
cellular signals via a single receptor subtype. Therefore, 
the existence of different receptor subtypes involved in 
mediating different signals, should also be evidenced with 
radioligand binding studies. In cantrast to functional 
agonist potencies, which are in addition dependent on 
parameters like "spare receptors" (Lohse et al. 1986), 
binding paramenters describe only the receptor recog-
nition site. Receptor classification on the basis of the 
signal transduction process has also been regarded as 
unsafe for cx-adrenergic receptors (McGrath and Wilson 
1988). The "variable receptor affinity hypothesis" pro-
vides another explanation for selective tissue responses, 
which may be dependent on the microenvironment ofthe 
receptors in different membranes (Bevan et al. 1989). All 
these factors may have contributed to the variations of 
the pharmacological profile for At type receptors, which 
led to the proposal of an A3 receptor (Ribeiro and 
Sebastiao 1986). The classification as an A3 receptor 
was based on functional data and mainly on different 
positions in the rank order of potency of NECA and 2-
chloroadenosine, compared with the classical A1 profile. 
Another problern for classification based on func-
tional studies emerges when ligands like NECA and 2-
chloroadenosine are used. These compounds have con-
siderable potencies at A2 receptors, which might influence 
the determination of the A 1 potency in different tissues 
to various degrees depending on the densities of A 1 and 
A2 receptors. This problern can be overcome in binding 
experiments with the highly A 1 selective radioligands 
( 3H]DPCPX and [3H]CCP A, which do not Iabel A2 re-
ceptors. 
Our data clearly show that comparing agonistproflies 
from different tissues with the classical profile from rat 
brain is not sufficient to propose new A 1 receptor sub-
types. The discrimination of receptor substypes requires 
comparison of binding and functional data within the 
same species. Functional data, however, may not match 
the binding profiles, because they are the matter ofmodu-
lation via a variety of different mechanisms, e.g. spare 
receptors or interaction of ligands with A 2 receptors. We 
propose using the brain A 1 receptor as the reference 
receptor and, therefore, provide binding data for brain 
membranes from a series of species. The highly A1 selec-
tive CCPA, the PIA enantiomers and NECA seem tobe 
reasonable means of defining agonist profiles in binding 
studies. 
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